Your institution may have access to this item. Find your institution then sign in to continue.
Title
Topical valrubicin application reduces skin inflammation in murine models.
Authors
Hauge, E; Christiansen, H; Rosada, C; de Darkó, E; Dam, T N; Stenderup, K
Abstract
Valrubicin is a cytostatic anthracycline analogue, lacking toxicity by skin and tissue contact, and represents a new drug with potential for topical treatment of psoriasis and nonmelanoma skin cancer (NMSC); the beneficial effects have been partly explained by its antiproliferative and proapoptotic characteristics.
Publication
The British journal of dermatology, 2012, Vol 167, Issue 2, p288